Literature DB >> 14613269

Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium.

Anne Roivainen1, Riitta Parkkola, Timo Yli-Kerttula, Pertti Lehikoinen, Tapio Viljanen, Timo Möttönen, Pirjo Nuutila, Heikki Minn.   

Abstract

OBJECTIVE: To compare positron emission tomography (PET) and magnetic resonance imaging (MRI) in the evaluation of inflammatory proliferation of synovium.
METHODS: Ten patients (mean +/- SD age 36 +/- 13 years) with inflammatory joint disease and with clinical signs of inflammation of the joint were studied. A new tracer for cellular proliferation, methyl-(11)C-choline ((11)C-choline), and a widely used tracer for the detection of inflammation and cancer, 2-(18)F-fluoro-2-deoxy-D-glucose ((18)F-FDG), were applied for PET imaging, and the results were compared with the findings from gadolinium diethylenetriaminepentaacetic acid-enhanced MR images. The uptake of (11)C-choline and (18)F-FDG in the inflamed synovium was measured and expressed as the standardized uptake value (SUV) and the kinetic influx constant (K(i)) obtained from graphic analysis, and these values were compared with quantitative values on MRI. Synovial volumes were measured on the coronal contrast-enhanced T1-weighted MR images using the standard software of the MR imager.
RESULTS: All patients showed high accumulation of both (11)C-choline and (18)F-FDG at the site of arthritic changes, where quantification of the tracer uptake was performed. The SUV of (11)C-choline was 1.5 +/- 0.9 gm/ml (mean +/- SD; n = 10) and the SUV of (18)F-FDG was 1.9 +/- 0.9 gm/ml (n = 10) (P = 0.017). The K(i) of (11)C-choline (mean +/- SD 0.048 +/- 0.042 minute(-1)) was 8-fold higher than the K(i) of (18)F-FDG (0.006 +/- 0.003 minute(-1)) (P = 0.009). Both the uptake of (11)C-choline and the uptake of (18)F-FDG correlated highly with the volume of synovium; the highest correlation was observed with the K(i) of (11)C-choline (r = 0.954, P < 0.0001).
CONCLUSION: In the use of PET scans,(11)C-choline can be regarded as a promising tracer for quantitative imaging of proliferative arthritis changes. Nevertheless, subsequent prospective studies with larger numbers of patients are necessary to further characterize the relationship between the findings on PET imaging and the clinical and functional measures of inflammation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14613269     DOI: 10.1002/art.11282

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  39 in total

Review 1.  Molecular characterization of rheumatoid arthritis with magnetic resonance imaging.

Authors:  Jeffrey T Gu; Linda Nguyen; Abhijit J Chaudhari; John D MacKenzie
Journal:  Top Magn Reson Imaging       Date:  2011-04

2.  Whole-body distribution of (11)C-choline and uptake in knee synovitis.

Authors:  Anne Roivainen; Timo Yli-Kerttula
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-25       Impact factor: 9.236

Review 3.  [Molecular imaging: future uses in arthritides].

Authors:  M H Brem; P M Schlechtweg; J Mackenzie; C S Winalski; P Lang
Journal:  Radiologe       Date:  2006-05       Impact factor: 0.635

4.  PET/MRI depicts the exact location of meniscal tear associated with synovitis.

Authors:  Ghassan El-Haddad; Rakesh Kumar; Ronaldo Pamplona; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-23       Impact factor: 9.236

Review 5.  Evolving role of FDG PET imaging in assessing joint disorders: a systematic review.

Authors:  Kathleen Carey; Babak Saboury; Sandip Basu; Alex Brothers; Alexis Ogdie; Tom Werner; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-14       Impact factor: 9.236

6.  High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot study.

Authors:  Abhijit J Chaudhari; Andrea Ferrero; Felipe Godinez; Kai Yang; David K Shelton; John C Hunter; Stanley M Naguwa; John M Boone; Siba P Raychaudhuri; Ramsey D Badawi
Journal:  Br J Radiol       Date:  2016-04-25       Impact factor: 3.039

7.  Correlation of 18F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs.

Authors:  Anne Roivainen; Sannamari Hautaniemi; Timo Möttönen; Pirjo Nuutila; Vesa Oikonen; Riitta Parkkola; Luminita Pricop; Rudyard Ress; Nicholas Seneca; Marko Seppänen; Timo Yli-Kerttula
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-15       Impact factor: 9.236

8.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

9.  PET assessment of disease activity in children with juvenile idiopathic arthritis.

Authors:  Ukihide Tateishi; Tomoyuki Imagawa; Noriko Kanezawa; Tetsuhiko Okabe; Kazuya Shizukuishi; Tomio Inoue; Shumpei Yokota
Journal:  Pediatr Radiol       Date:  2010-06-04

10.  Correlation of PUV and SUV in the extremities while using PEM as a high-resolution positron emission scanner.

Authors:  Sania Rahim; Osama Mawlawi; Patricia Fox; Shree Taylor; Richelle Millican; Nancy M Swanston; J Elliott Brown; Eric M Rohren
Journal:  Skeletal Radiol       Date:  2014-01-16       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.